Jamilah Abusarah

440 total citations
20 papers, 303 citations indexed

About

Jamilah Abusarah is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jamilah Abusarah has authored 20 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jamilah Abusarah's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Jamilah Abusarah is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Jamilah Abusarah collaborates with scholars based in Canada, Lebanon and Brazil. Jamilah Abusarah's co-authors include Moutih Rafei, Mohamed Benderdour, Riam Shammaa, Abed El-Hakim El-Kadiry, Julio Fernandes, Hassan Fahmi, Qin Shi, Fátima Pereira de Souza, Johanne Martel‐Pelletier and Ghayath Baroudi and has published in prestigious journals such as Frontiers in Immunology, Journal of Cellular Biochemistry and Osteoarthritis and Cartilage.

In The Last Decade

Jamilah Abusarah

19 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jamilah Abusarah Canada 10 109 67 61 61 52 20 303
Haijie Ji China 9 118 1.1× 56 0.8× 145 2.4× 52 0.9× 54 1.0× 13 382
Jeremy S. Haley United States 9 110 1.0× 58 0.9× 71 1.2× 110 1.8× 65 1.3× 21 402
Hongsong Fang China 10 212 1.9× 36 0.5× 40 0.7× 40 0.7× 95 1.8× 13 472
Shangxue Yan China 10 128 1.2× 130 1.9× 23 0.4× 107 1.8× 77 1.5× 21 361
Changhao Xie China 9 89 0.8× 103 1.5× 13 0.2× 87 1.4× 35 0.7× 38 269
Gengyi Zou United States 8 139 1.3× 39 0.6× 25 0.4× 36 0.6× 51 1.0× 15 296
Yiping Hu China 12 194 1.8× 89 1.3× 15 0.2× 133 2.2× 57 1.1× 28 450
Huilin Yang China 10 176 1.6× 75 1.1× 9 0.1× 72 1.2× 45 0.9× 13 360

Countries citing papers authored by Jamilah Abusarah

Since Specialization
Citations

This map shows the geographic impact of Jamilah Abusarah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamilah Abusarah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamilah Abusarah more than expected).

Fields of papers citing papers by Jamilah Abusarah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamilah Abusarah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamilah Abusarah. The network helps show where Jamilah Abusarah may publish in the future.

Co-authorship network of co-authors of Jamilah Abusarah

This figure shows the co-authorship network connecting the top 25 collaborators of Jamilah Abusarah. A scholar is included among the top collaborators of Jamilah Abusarah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamilah Abusarah. Jamilah Abusarah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abusarah, Jamilah, Nehmé El-Hachem, Sébastien Talbot, et al.. (2024). A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses. iScience. 27(3). 109248–109248. 1 indexed citations
2.
El-Hachem, Nehmé, Jamilah Abusarah, Gabrielle A. Mandl, et al.. (2024). Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth. Journal of Translational Medicine. 22(1). 532–532.
3.
Abusarah, Jamilah, et al.. (2024). An engineered Accum‐E7 protein‐based vaccine with dual anti‐cervical cancer activity. Cancer Science. 115(4). 1102–1113. 6 indexed citations
4.
El-Hachem, Nehmé, Christine Lawson, Lee‐Hwa Tai, et al.. (2023). Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors. Cancer Science. 114(12). 4499–4510. 3 indexed citations
5.
Beaudoin, Simon, Mohammad Balood, Jamilah Abusarah, et al.. (2022). Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity. Cell Reports Medicine. 3(3). 100534–100534. 13 indexed citations
6.
El-Hachem, Nehmé, Jamilah Abusarah, Nicoletta Eliopoulos, et al.. (2022). The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells. iScience. 25(12). 105537–105537. 1 indexed citations
7.
8.
Abusarah, Jamilah, et al.. (2022). CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties. Cells. 11(15). 2263–2263. 13 indexed citations
9.
Abusarah, Jamilah, Nehmé El-Hachem, Martin Olivier, et al.. (2021). Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice. Cell Reports Medicine. 2(12). 100455–100455. 20 indexed citations
10.
El-Hachem, Nehmé, et al.. (2021). Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells. Frontiers in Immunology. 11. 596303–596303. 9 indexed citations
11.
Abusarah, Jamilah, Nehmé El-Hachem, Martin Olivier, et al.. (2021). Engineering a Potent Cancer Vaccine Using Immunoproteasome-Expressing Mesenchymal Stromal Cells. SSRN Electronic Journal. 1 indexed citations
12.
Abusarah, Jamilah, Nehmé El-Hachem, Abed El-Hakim El-Kadiry, et al.. (2020). TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity. Molecular Cancer Therapeutics. 20(1). 37–49. 4 indexed citations
13.
El-Kadiry, Abed El-Hakim, Jamilah Abusarah, Nehmé El-Hachem, et al.. (2020). A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties. Frontiers in Pharmacology. 11. 237–237. 4 indexed citations
14.
Shammaa, Riam, Abed El-Hakim El-Kadiry, Jamilah Abusarah, & Moutih Rafei. (2020). Mesenchymal Stem Cells Beyond Regenerative Medicine. Frontiers in Cell and Developmental Biology. 8. 72–72. 67 indexed citations
15.
Abusarah, Jamilah, et al.. (2017). An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis. Inflammation Research. 66(8). 637–651. 39 indexed citations
16.
Abusarah, Jamilah, Qin Shi, Bertrand Lussier, et al.. (2016). Elucidating the Role of Protandim and 6‐Gingerol in Protection Against Osteoarthritis. Journal of Cellular Biochemistry. 118(5). 1003–1013. 48 indexed citations
17.
Abusarah, Jamilah, Qin Shi, Hassan Fahmi, Julio Fernandes, & Mohamed Benderdour. (2014). The role of NRF2 transcription factor in osteoarthritis. Osteoarthritis and Cartilage. 22. S146–S146. 1 indexed citations
18.
Golizeh, Makan, Jamilah Abusarah, Mohamed Benderdour, & Lekha Sleno. (2014). Covalent Binding of 4-Hydroxynonenal to Matrix Metalloproteinase 13 Studied by Liquid Chromatography–Mass Spectrometry. Chemical Research in Toxicology. 27(9). 1556–1565. 16 indexed citations
19.
Shi, Qin, Jamilah Abusarah, Charlotte Zaouter, et al.. (2014). New Evidence Implicating 4‐Hydroxynonenal in the Pathogenesis of Osteoarthritis In Vivo. Arthritis & Rheumatology. 66(9). 2461–2471. 25 indexed citations
20.
Shi, Qin, Jamilah Abusarah, Ghayath Baroudi, et al.. (2012). Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis. Arthritis Research & Therapy. 14(5). R223–R223. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haijie Ji Breakdown of academic impact, for papers by Jeremy S. Haley Breakdown of academic impact, for papers by Hongsong Fang Breakdown of academic impact, for papers by Shangxue Yan Breakdown of academic impact, for papers by Changhao Xie Breakdown of academic impact, for papers by Gengyi Zou Breakdown of academic impact, for papers by Yiping Hu Breakdown of academic impact, for papers by Huilin Yang
Rankless by CCL
2026